# Switching From Wegovy to Compounded Semaglutide: The Complete 2026 Guide
Wegovy works. For many people it is the first medication that finally quiets the constant food noise and makes a calorie deficit feel sustainable. The problem is rarely the medicine. It is the bill.
Brand-name Wegovy lists around $1,349 a month, and a large share of insurance plans either exclude weight-loss medications entirely or bury them behind prior authorization and high coinsurance. So a fair number of patients on Wegovy start asking the same question: can I stay on semaglutide, keep my progress, and pay less? For many, the answer is a physician-supervised switch to compounded semaglutide.
This guide explains why patients make the move, exactly how the dose transition works, what to expect on cost and supply, and the questions to ask before you change anything.
Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered. Compounded medications are prescribed by US-licensed physicians and prepared by state-licensed compounding pharmacies. This article is educational and is not medical advice. Individual results vary.
Same molecule, different product
This is the part that confuses people, so it is worth being precise.
Wegovy and compounded semaglutide both deliver semaglutide, the GLP-1 receptor agonist that reduces appetite and slows gastric emptying. The active ingredient that does the work is the same. What differs is everything around it.
| Brand-name Wegovy | Compounded semaglutide | |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| FDA status | FDA-approved final product | Not an FDA-approved final product |
| How it is made | Mass-manufactured by Novo Nordisk | Prepared by a state-licensed compounding pharmacy for an individual patient |
| Form | Prefilled pen, fixed dose strengths | Typically a vial, dose set by your prescriber |
| Typical price | About $1,349 a month list | Lower all-in cash price, varies by provider |
| Paid by | Insurance when covered, often with prior authorization | Out of pocket |
The takeaway: switching from Wegovy to compounded semaglutide is not switching to a different drug. It is changing how the same drug is sourced, regulated, and priced.
Why patients switch from Wegovy to compounded semaglutide
There are three reasons, and cost leads by a wide margin.
1. Cost. This is the headline. When a plan excludes weight-loss medication or places Wegovy on a non-preferred tier, the out-of-pocket cost can be enormous, sometimes close to the full list price. A compounded cash price through a licensed telehealth provider is frequently lower, and it is predictable. There is no prior-authorization gauntlet and no surprise pharmacy total.
2. Supply. Brand-name GLP-1 products have gone through periods of shortage and back-order. Patients who have had a prescription sit unfilled understand how disruptive a gap in GLP-1 therapy can be. A reliable compounded supply can remove that uncertainty.
3. Simplicity. A telehealth model that bundles the physician consultation, the medication, and shipping into one monthly price appeals to people who want fewer moving parts than the pharmacy-plus-insurance-plus-prior-authorization cycle.
None of these reasons override the one rule that matters most: the switch is a clinical decision, made with a US-licensed physician.
How the dose transition actually works
This is where people most need accurate information, because the internet is full of homemade conversion math that can be dangerous.
Here is the principle. Because Wegovy and compounded semaglutide are both semaglutide, the goal of a switch is usually to maintain your current effective weekly dose rather than restart the titration ladder from the bottom. If you are stable on a given weekly Wegovy dose, your physician will generally aim to keep you near that same weekly amount of semaglutide on the compounded product, then adjust based on tolerability and results.
The wrinkle is concentration. Wegovy comes in fixed pen strengths. Compounded semaglutide may be supplied at a different concentration, which means the injection volume that delivers your dose can look different from what you are used to with the pen. This is exactly why the dose and volume must be set by your prescriber and printed on your instructions. Do not assume the same number of clicks or the same volume carries over.
What a careful transition looks like in practice:
Never estimate the conversion yourself. Dosing errors are the single most common avoidable problem when switching GLP-1 products, and they cut both ways: too little blunts your results, too much raises the risk of gastrointestinal side effects.
Will you lose your progress?
This is the fear that keeps people on an expensive product longer than they need to be. The reassuring reality is that because the active ingredient is identical, a physician-managed switch that holds your effective weekly dose is designed to continue your treatment without a reset. The whole point of matching your dose is to avoid a gap in appetite control.
Some patients report minor differences in how a new product feels during the first couple of weeks. That is why follow-up matters. Your prescriber can adjust the dose if your appetite control or tolerability shifts. Weight management is never about the molecule alone; it depends on the full picture of nutrition, activity, sleep, and consistency. The medication is the lever, not the whole machine.
The cost comparison, done honestly
The reason most people read this article is the money, so here is the fair version of the comparison.
Brand-name Wegovy lists around $1,349 a month. Very few people pay that exact figure, but the real out-of-pocket cost depends entirely on your plan:
Compounded semaglutide through a licensed telehealth provider is typically priced as a transparent all-in monthly cash amount. The honest comparison is your actual out-of-pocket Wegovy cost, including any prior-authorization friction, versus the compounded cash price. For many patients without strong weight-loss coverage, the compounded route is the lower total cost. For the underlying numbers, see our guide to compounded semaglutide cost in 2026.
What about HSA and FSA?
Even though compounded semaglutide is paid out of pocket, you can often still pay with pre-tax dollars. Health Savings Accounts and Flexible Spending Accounts generally allow prescription medications prescribed by a licensed physician for a legitimate medical purpose. Some administrators ask for a Letter of Medical Necessity. Using pre-tax funds effectively lowers the net cost further. Confirm the rules with your HSA or FSA provider first. We cover this in more depth in our guide to whether insurance covers compounded GLP-1 medications.
Questions to ask before you switch
Bring these to your telehealth consultation. Good answers are a sign you are dealing with a legitimate provider.
1. What dose will I start on, and how does it match my current Wegovy dose? You want a clear, physician-set answer, not a generic chart. 2. What concentration is the compounded semaglutide, and what injection volume delivers my dose? This is the practical detail that prevents dosing errors. 3. Which pharmacy prepares the medication, and is it a state-licensed US compounding pharmacy? A provider that will not name its pharmacy is a red flag. 4. Who are the prescribing physicians, and are they US-licensed? GLP-1 therapy should be managed by a licensed clinician, not a faceless order form. 5. What is the all-in monthly price, and what does it include? Look for consultation, medication, and shipping bundled with no hidden fees.
How to spot a provider worth switching to
Because compounded medications are not FDA-approved final products, the provider you choose matters more than usual. Look for:
Avoid any source that will not name its pharmacy, ships from outside the US, sells without a physician consultation, or promises specific weight-loss results. Those are the markers of the operations that give the category a bad name.
The bottom line
Switching from Wegovy to compounded semaglutide keeps you on the same active ingredient while changing how it is sourced and priced. For patients whose insurance does not cover Wegovy well, it is often a lower-cost, more predictable way to stay on semaglutide, provided the switch is managed by a US-licensed physician and the medication comes from a state-licensed compounding pharmacy. The molecule does the work either way. What changes is the bill and the paperwork.
If you want to see whether a compounded semaglutide program fits your goals and budget, start your 2-minute medical assessment at /quiz to find out if you qualify. To compare your options first, read our breakdowns of compounded semaglutide vs Wegovy and Wegovy alternatives.
This article is for educational purposes only and is not medical advice. Compounded medications are not FDA-approved as final products. The active pharmaceutical ingredient is FDA-registered. Always consult a licensed healthcare provider about your individual situation. Individual results may vary.
Frequently Asked Questions
Is compounded semaglutide the same as Wegovy?
Both contain the same active ingredient, semaglutide, which is the GLP-1 medication that drives appetite reduction and weight loss. The difference is regulatory and how the product is made. Wegovy is a brand-name product that has gone through the full FDA approval process and is sold as a prefilled pen at a fixed set of dose strengths. Compounded semaglutide is prepared by a state-licensed compounding pharmacy for an individual patient using an FDA-registered active pharmaceutical ingredient, and the compounded final product is not FDA-approved. The molecule is the same; the manufacturing, regulatory status, and price are different.
Why do people switch from Wegovy to compounded semaglutide?
The most common reason is cost. Brand-name Wegovy lists around $1,349 a month, and many insurance plans either exclude weight-loss medications or require prior authorization. Compounded semaglutide through a licensed telehealth provider is typically priced as a lower all-in cash amount. The second common reason is supply, since brand-name GLP-1 products have experienced periods of shortage. Some patients also prefer the predictable monthly pricing and the simpler telehealth process. The switch should always be made with a US-licensed physician, not on your own.
How does the dose transition from Wegovy to compounded semaglutide work?
Because both medications are semaglutide, a physician will generally aim to match your current weekly Wegovy dose as closely as possible on the compounded product, then continue from there. Compounded semaglutide may be supplied at different concentrations than the fixed Wegovy pen strengths, so your prescriber sets the exact dose and injection volume. This is a clinical decision that depends on your current dose, how well you tolerate the medication, and your progress. Never estimate the conversion yourself; dosing errors are the most common avoidable problem when changing products.
Will I lose progress switching from Wegovy to compounded semaglutide?
Because the active ingredient is identical, a physician-managed switch that maintains your effective weekly dose is designed to continue your treatment without restarting the titration ladder from the bottom. The goal of matching your current dose is to avoid a gap in appetite control. Some patients notice minor differences in how a new product feels during the first few weeks. Keep your follow-up appointments so your prescriber can adjust if needed. Individual results vary, and weight management always depends on the full picture of diet, activity, and consistency.
Is compounded semaglutide cheaper than Wegovy?
For most patients without strong weight-loss coverage, yes. Brand-name Wegovy lists around $1,349 a month, and if your plan excludes weight-loss drugs or places semaglutide on a high-coinsurance tier, your real out-of-pocket cost can be very high. Compounded semaglutide through a licensed telehealth provider is typically a lower all-in cash price that bundles the consultation, medication, and shipping. The honest comparison is your actual out-of-pocket Wegovy cost, including any prior-authorization process, versus the compounded cash price. Pricing varies by provider and dose.
Is it safe to switch from Wegovy to compounded semaglutide?
When the switch is supervised by a US-licensed physician and the medication is prepared by a state-licensed compounding pharmacy, it follows the same clinical principles as any GLP-1 dose management. The safety priorities are accurate dosing, an appropriate titration plan, and ongoing follow-up. Compounded medications are not FDA-approved final products, so it matters where you get them: look for a provider that names its pharmacy, uses US-licensed physicians, and labels the product honestly. Avoid any source that ships from outside the US or promises specific results. This article is educational and is not medical advice.
All Majesta Health medical content is clinically reviewed before publication by US-licensed physicians affiliated with our clinical infrastructure partner, MD Integrations (MDI). Reviewers hold active state medical licenses, are board-certified in primary care or obesity medicine, and specialize in GLP-1 receptor agonist therapy for chronic weight management. MDI is LegitScript certified and SOC 2 Type II accredited.
- US-licensed physicians affiliated with our clinical partner MD Integrations (LegitScript certified, HIPAA, SOC 2 Type II, ISO certified)
- Board-certified in primary care and obesity medicine
- Active state medical licensure required for every prescribing clinician
- Active DEA registration where applicable (note: GLP-1 medications are not controlled substances)
- Telehealth practice across all 50 US states and DC through the MD Integrations Medical Services Organization
- Dispensing pharmacy partner: Belmar Pharma Solutions (LegitScript certified, NABP accredited, 503A and 503B compounding)